Top News
Dr Reddy’s Arm Reports Positive Results from Phase 1 Study
Ribrecabtagene autoleucel is an autologous CAR-T therapy that uses a humanized single-domain antibody as its binding domain. The clinical trials for DRL-1801 ar...
- Business
- 08 Oct, 2024
- 2 Min Read
Take your investment to next level
Open a FREE* Demat and Trading account to invest in Stocks, Mutual Funds, IPOs and more
Business News
Dr Reddy’s Arm Reports Positive Results from Phase 1 Study
- 08 Oct, 2024
- 2 Min Read
Allied Digital Awarded Pune Safe City Project Worth 430 Cr
- 08 Oct, 2024
- 3 Min Read
Earnings News
Gujchem Distillers Q2 YoY Net Profit Soars Over 299%
- 08 Oct, 2024
- 1 Min Read
Himalaya Food Int Q2 FY25 Net Profit Skyrockets 101% Y-o-Y to Rs 2.05 Cr
- 07 Oct, 2024
- 2 Min Read
IPO News
Paramount Dye Tec Limited Launches IPO Offering 24.3 Lakh Shares
- 04 Oct, 2024
- 2 Min Read
Sahasra Electronics Solutions Limited IPO Details
- 04 Oct, 2024
- 2 Min Read
Market News
Antony Waste Shares Surge 5% on Arm’s Contract Win
- 07 Oct, 2024
- 2 Min Read
Diffusion Engineers makes a strong debut
- 04 Oct, 2024
- 2 Min Read